Express Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Who Owns Your Media: The Indian Express empire and where it stands today

Feb 19, 2021 9:41am The FDA hit India's Shilpa with an import alert on all but three of its drugs after the company failed to address problems cited in an October warning letter. (Pixabay/qimono) Just a few months after India-based drugmaker Shilpa Medicare found itself in the FDA's crosshairs, the company now faces a ban on the vast majority of its products in the U.S.  The FDA slapped an import alert on Shilpa Medicare's formulation plant in Telangana, India, according to a notice posted Thursday. The product ban comes on the heels of an FDA warning letter that cited the Indian drugm...